vendredi 19 mai 2017
Opioid conflict-of-interest controversy reveals extent of big pharma's ties to doctors
Controversy over drug industry conflicts on opioid-prescribing guidelines has Ottawa asking questions. But industry influence on doctors is widespread and widely accepted — if rarely discussed.
Articles
0 comments:
Enregistrer un commentaire